|
National Stock Number(NSN): 6505-01-025-8582 (6505010258582, 010258582)
| NIIN: |
01-025-8582 |
Item Name: |
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES |
INC: |
30795
|
| FSC: |
6505
|
Assignment Date: |
Aug-11-1976 |
CRIT: |
X |
IIG: |
30795 |
| ISC: |
5 |
Date Standardized: |
Aug-11-1976 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Nov-01-2024 |
PMIC: |
U |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.49.0020 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
4 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
3 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
76822 |
04493
|
HOFFMANN-LA ROCHE INC. |
H |
3 |
2 |
6 |
75 |
4 |
D |
|
|
|
|
|
LIBRIUM |
04493
|
HOFFMANN-LA ROCHE INC. |
H |
3 |
2 |
6 |
75 |
1 |
D |
|
|
|
|
|
NDC00140-0003-52 |
04493
|
HOFFMANN-LA ROCHE INC. |
H |
3 |
2 |
6 |
75 |
1 |
D |
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| VA |
JVS |
I |
|
S |
Q |
G |
V |
$0.00 |
BT |
|
------- |
Mar-01-1991 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| VA |
K |
U/I CONTAINS 90 EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
POWDER |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
90.000 |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|